(Q36128954)

12 August 2017

1 reference

title

Use of mode of action in risk assessment: past, present, and future (English)

1 reference

12 August 2017

Harvey Clewell

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

24 February 2005

1 reference

Regulatory Toxicology and Pharmacology

12 August 2017

published in

1 reference

12 August 2017

volume

42

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

3-14

1 reference

Is ingested inorganic arsenic a "threshold" carcinogen?

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Mode-of-action-based dosimeters for interspecies extrapolation of vinyl acetate inhalation risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Incorporating biological information in quantitative risk assessment: an example with methylene chloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Requirements for a Biologically Realistic Cancer Risk Assessment for Inorganic Arsenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Evolution of science-based uncertainty factors in noncancer risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Regulatory history and experimental support of uncertainty (safety) factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Applications of mechanistic data in risk assessment: the past, present, and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Development validation and problems with the toxic equivalency factor approach for risk assessment of dioxins and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Backing into cancer: effects of arsenic on cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.008

10.1016/J.YRTPH.2005.01.008

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference